Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.5.1.1 (
asparaginase
)
2,695
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
High level expression of recombinant proteins in bacteria often results in their aggregation into inclusion bodies. Formation of inclusion bodies poses a major bottleneck in high-throughput recovery of recombinant protein. These aggregates have amyloid-like nature and can retain biological activity. Here, effect of expression temperature on the quality of
Escherichia coli
asparaginase II
(a tetrameric protein) inclusion bodies was evaluated. Asparaginase was expressed as inclusion bodies at different temperatures. Purified inclusion bodies were checked for biological activities and analyzed for structural properties in order to establish a structure-activity relationship. Presence of activity in inclusion bodies showed the existence of properly folded
asparaginase
tetramers. Expression temperature affected the properties of
asparaginase
inclusion bodies. Inclusion bodies expressed at higher temperatures were characterized by higher biological activity and less amyloid content as evident by
Thioflavin T
binding and Fourier Transform Infrared (FTIR) spectroscopy. Complex kinetics of proteinase K digestion of
asparaginase
inclusion bodies expressed at higher temperatures indicate higher extent of conformational heterogeneity in these aggregates.
...
PMID:Structure-Function Relationship of Inclusion Bodies of a Multimeric Protein. 3245 30